Manufacture and sell a wide range of cosmetic products for women and men globally. Now — the numbers.
This is an established company with proven profits.
Average growth of 8% a year over the last 4 years. Every year shown ended in profit.
The gap is $2.4B. In times of high interest rates, a gap like that can squeeze a company.
The market pays 33× for every dollar this company earns in a year — a price that already assumes things go well.
Analysts' average target sits 14% above today's price.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
R&D Investment: Spending on future research is low.
The stock trades below its recent peak — about 12% off the top. A pullback, not a collapse.
Over the last 4 years, sales grew about 8% a year on average.
It pays out $1.68 per share each year — regular cash for whoever holds the stock.
The company’s market value is 33 times its annual profit. Even a small disappointment could hit the price hard.
The price action doesn’t yet back an upward turn. Council score: 0/10.
The share set aside for the future is small; the pace of new ideas may slow. Council score: 2/10.
Against everything we grade, LRLCY lands near the bottom. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: LRLCY does earn real profits — but on our report card it still sits behind its class. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.
Not covered, because the filings we hold do not carry it: the revenue breakdown.